Free Trial

Cytosorbents (CTSO) Competitors

Cytosorbents logo
$0.87 +0.02 (+2.26%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$0.84 -0.03 (-3.47%)
As of 08/1/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CTSO vs. SMTI, SKIN, BWAY, CVRX, MGRM, PTHL, CV, INGN, SGHT, and TLSI

Should you be buying Cytosorbents stock or one of its competitors? The main competitors of Cytosorbents include Sanara MedTech (SMTI), Beauty Health (SKIN), Brainsway (BWAY), CVRx (CVRX), Monogram Orthopaedics (MGRM), Pheton (PTHL), CapsoVision (CV), Inogen (INGN), Sight Sciences (SGHT), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry.

Cytosorbents vs. Its Competitors

Sanara MedTech (NASDAQ:SMTI) and Cytosorbents (NASDAQ:CTSO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Sanara MedTech currently has a consensus price target of $49.50, indicating a potential upside of 104.88%. Cytosorbents has a consensus price target of $5.50, indicating a potential upside of 532.77%. Given Cytosorbents' higher possible upside, analysts clearly believe Cytosorbents is more favorable than Sanara MedTech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanara MedTech
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cytosorbents
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Sanara MedTech has a net margin of -12.48% compared to Cytosorbents' net margin of -41.77%. Sanara MedTech's return on equity of -29.22% beat Cytosorbents' return on equity.

Company Net Margins Return on Equity Return on Assets
Sanara MedTech-12.48% -29.22% -13.20%
Cytosorbents -41.77%-105.04%-29.18%

8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 32.9% of Cytosorbents shares are held by institutional investors. 42.6% of Sanara MedTech shares are held by insiders. Comparatively, 7.3% of Cytosorbents shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Sanara MedTech has higher revenue and earnings than Cytosorbents. Sanara MedTech is trading at a lower price-to-earnings ratio than Cytosorbents, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sanara MedTech$86.67M2.48-$9.66M-$1.34-18.03
Cytosorbents$35.33M1.54-$20.72M-$0.28-3.10

In the previous week, Cytosorbents had 3 more articles in the media than Sanara MedTech. MarketBeat recorded 3 mentions for Cytosorbents and 0 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 0.00 equaled Cytosorbents'average media sentiment score.

Company Overall Sentiment
Sanara MedTech Neutral
Cytosorbents Neutral

Sanara MedTech has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Cytosorbents has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500.

Summary

Sanara MedTech beats Cytosorbents on 10 of the 15 factors compared between the two stocks.

Get Cytosorbents News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTSO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTSO vs. The Competition

MetricCytosorbentsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$54.42M$10.40B$5.49B$9.52B
Dividend YieldN/A1.99%4.73%4.09%
P/E Ratio-3.1018.4228.7823.81
Price / Sales1.5429.01372.2066.04
Price / CashN/A22.3135.4557.96
Price / Book4.353.478.275.54
Net Income-$20.72M$234.77M$3.25B$259.28M
7 Day Performance-7.88%-4.82%-3.70%-4.64%
1 Month Performance-13.08%1.80%4.34%4.41%
1 Year Performance-27.57%-12.51%25.90%17.95%

Cytosorbents Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTSO
Cytosorbents
1.1869 of 5 stars
$0.87
+2.3%
$5.50
+532.8%
-24.4%$54.42M$35.33M-3.10220News Coverage
Upcoming Earnings
Gap Up
High Trading Volume
SMTI
Sanara MedTech
1.599 of 5 stars
$25.03
-2.0%
$49.50
+97.8%
-19.4%$226.91M$86.67M-18.6860
SKIN
Beauty Health
1.4975 of 5 stars
$1.76
-1.7%
$1.13
-36.1%
-10.0%$225.53M$334.30M-4.291,030Trending News
Upcoming Earnings
Analyst Forecast
BWAY
Brainsway
3.2569 of 5 stars
$12.00
+2.3%
$14.25
+18.8%
+64.6%$221.67M$41.02M60.00120News Coverage
Upcoming Earnings
CVRX
CVRx
2.7029 of 5 stars
$8.43
+1.1%
$14.50
+72.0%
-8.9%$217.45M$51.29M-3.87160Upcoming Earnings
Gap Down
MGRM
Monogram Orthopaedics
1.3206 of 5 stars
$5.69
+0.2%
$5.40
-5.1%
+128.4%$202.71M$370K-12.6428News Coverage
Positive News
PTHL
Pheton
N/A$30.96
+6.2%
N/AN/A$191.87M$450K0.0011News Coverage
Positive News
CV
CapsoVision
N/A$4.35
+8.8%
$5.50
+26.4%
N/A$185.38MN/A0.0090News Coverage
Positive News
Analyst Revision
INGN
Inogen
4.2122 of 5 stars
$6.79
-0.1%
$11.00
+62.0%
-31.8%$182.83M$335.70M-5.901,030Upcoming Earnings
SGHT
Sight Sciences
2.0932 of 5 stars
$3.54
+1.4%
$3.93
+11.1%
-55.9%$180.42M$79.87M-3.61210
TLSI
TriSalus Life Sciences
2.2113 of 5 stars
$4.55
-0.2%
$10.75
+136.3%
-27.9%$172.55M$29.43M-4.06106

Related Companies and Tools


This page (NASDAQ:CTSO) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners